264 related articles for article (PubMed ID: 16372828)
1. Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.
Thomas F; Séronie-Vivien S; Gladieff L; Dalenc F; Durrand V; Malard L; Lafont T; Poublanc M; Bugat R; Chatelut E
Clin Pharmacokinet; 2005; 44(12):1305-16. PubMed ID: 16372828
[TBL] [Abstract][Full Text] [Related]
2. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Schmitt A; Gladieff L; Lansiaux A; Bobin-Dubigeon C; Etienne-Grimaldi MC; Boisdron-Celle M; Serre-Debauvais F; Pinguet F; Floquet A; Billaud E; Le Guellec C; Penel N; Campone M; Largillier R; Capitain O; Fabbro M; Houede N; Medioni J; Bougnoux P; Lochon I; Chatelut E
Clin Cancer Res; 2009 May; 15(10):3633-9. PubMed ID: 19401344
[TBL] [Abstract][Full Text] [Related]
3. GFR is better estimated by considering both serum cystatin C and creatinine levels.
Bouvet Y; Bouissou F; Coulais Y; Séronie-Vivien S; Tafani M; Decramer S; Chatelut E
Pediatr Nephrol; 2006 Sep; 21(9):1299-306. PubMed ID: 16794818
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children.
Narvaez-Sanchez R; Gonzalez L; Salamanca A; Silva M; Rios D; Arevalo S; Gastelbondo R; Sanchez J
Clin Biochem; 2008 May; 41(7-8):498-503. PubMed ID: 18280806
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C is a better marker of topotecan clearance than serum creatinine.
Hoppe A; Séronie-Vivien S; Thomas F; Delord JP; Malard L; Canal P; Chatelut E
Clin Cancer Res; 2005 Apr; 11(8):3038-44. PubMed ID: 15837759
[TBL] [Abstract][Full Text] [Related]
6. Comparison of creatinine and cystatin formulae with
Cholongitas E; Ioannidou M; Goulis I; Chalevas P; Ntogramatzi F; Athanasiadou Z; Notopoulos A; Alevroudis M; Sinakos E; Akriviadis E
J Gastroenterol Hepatol; 2017 Jan; 32(1):191-198. PubMed ID: 27177318
[TBL] [Abstract][Full Text] [Related]
7. A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function.
Viberg A; Lannergård A; Larsson A; Cars O; Karlsson MO; Sandström M
Br J Clin Pharmacol; 2006 Sep; 62(3):297-303. PubMed ID: 16934045
[TBL] [Abstract][Full Text] [Related]
8. Derivation and validation of cystatin C-based prediction equations for GFR in children.
Zappitelli M; Parvex P; Joseph L; Paradis G; Grey V; Lau S; Bell L
Am J Kidney Dis; 2006 Aug; 48(2):221-30. PubMed ID: 16860187
[TBL] [Abstract][Full Text] [Related]
9. Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.
Visvardis G; Griveas I; Zilidou R; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou A; Sakellariou G
Transplant Proc; 2004; 36(6):1757-9. PubMed ID: 15350470
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function.
Kasai H; Tsuji Y; Hiraki Y; Tsuruyama M; To H; Yamamoto Y
J Infect Chemother; 2018 Apr; 24(4):284-291. PubMed ID: 29292178
[TBL] [Abstract][Full Text] [Related]
11. Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates.
Risch L; Blumberg A; Huber AR
Ren Fail; 2001; 23(3-4):439-48. PubMed ID: 11499559
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients.
Séronie-Vivien S; Toullec S; Malard L; Thomas F; Durrand V; Chatelut E
Med Oncol; 2006; 23(1):63-73. PubMed ID: 16645231
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C: an improved estimator of glomerular filtration rate?
Laterza OF; Price CP; Scott MG
Clin Chem; 2002 May; 48(5):699-707. PubMed ID: 11978596
[TBL] [Abstract][Full Text] [Related]
14. Estimating renal function in children: a new GFR-model based on serum cystatin C and body cell mass.
Andersen TB
Dan Med J; 2012 Jul; 59(7):B4486. PubMed ID: 22759853
[TBL] [Abstract][Full Text] [Related]
15. Utility of cystatin C and serum creatinine-based glomerular filtration rate equations in predicting vancomycin clearance: A population pharmacokinetics analysis in elderly Chinese patients.
Ling J; Yang X; Dong L; Jiang Y; Zou S; Hu N
Biopharm Drug Dispos; 2024 Feb; 45(1):58-68. PubMed ID: 38319316
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.
Bodnar L; Stec R; Dzierżanowska M; Synowiec A; Cierniak S; Kade G; Szczylik C
Cancer Chemother Pharmacol; 2016 Aug; 78(2):295-304. PubMed ID: 27324020
[TBL] [Abstract][Full Text] [Related]
17. Flat dosing of carboplatin is justified in adult patients with normal renal function.
Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
[TBL] [Abstract][Full Text] [Related]
18. The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations.
Wagner D; Kniepeiss D; Stiegler P; Zitta S; Bradatsch A; Robatscher M; Müller H; Meinitzer A; Fahrleitner-Pammer A; Wirnsberger G; Iberer F; Tscheliessnigg K; Reibnegger G; Rosenkranz AR
Transpl Int; 2012 May; 25(5):527-36. PubMed ID: 22369048
[TBL] [Abstract][Full Text] [Related]
19. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
20. GFR estimation using cystatin C is not independent of body composition.
Macdonald J; Marcora S; Jibani M; Roberts G; Kumwenda M; Glover R; Barron J; Lemmey A
Am J Kidney Dis; 2006 Nov; 48(5):712-9. PubMed ID: 17059990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
